Status:
COMPLETED
A Novel Probiotic Mixture in Adults With IBS
Lead Sponsor:
University of Bari
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Irritable bowel syndrome (IBS) is faced by gastroenterologists on a daily basis and probiotics are a potential therapeutic tool, however, there is no strain recommendations. This multicenter re-al-wor...
Detailed Description
Irritable bowel syndrome (IBS) is faced by gastroenterologists on a daily basis and probiotics are a potential therapeutic tool, however, there is no strain recommendations. This multicenter re-al-wor...
Eligibility Criteria
Inclusion
- recurrent abdominal pain at least once per week during the past three months associated with two or more of the following criteria:
- related to defecation,
- Associated with a change in the frequency of stool,
- Associated with a change in the appearance of stool.
Exclusion
- none
Key Trial Info
Start Date :
October 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
1098 Patients enrolled
Trial Details
Trial ID
NCT06610149
Start Date
October 1 2022
End Date
August 31 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Pediatrica
Bari, Apulia, Italy, 70125